Literature DB >> 35316461

Truncation of the N-terminus of cardiac troponin I initiates adaptive remodeling of the myocardial proteosome via phosphorylation of mechano-sensitive signaling pathways.

Chad M Warren1, Monika Halas1, Paul H Goldspink1, Han-Zhong Feng1,2, Anthony W Herren3, Beata M Wolska1,4, Pieter P de Tombe1,5, Jian-Ping Jin1,2, R John Solaro6.   

Abstract

The cardiac isoform of troponin I has a unique N-terminal extension (~ 1-30 amino acids), which contributes to the modulation of cardiac contraction and relaxation. Hearts of various species including humans produce a truncated variant of cardiac troponin I (cTnI-ND) deleting the first ~ 30 amino acids as an adaption in pathophysiological conditions. In this study, we investigated the impact of cTnI-ND chronic expression in transgenic mouse hearts compared to wildtype (WT) controls (biological n = 8 in each group). We aimed to determine the global phosphorylation effects of cTnI-ND on the cardiac proteome, thereby determining the signaling pathways that have an impact on cardiac function. The samples were digested and isobarically labeled and equally mixed for relative quantification via nanoLC-MS/MS. The peptides were then enriched for phospho-peptides and bioinformatic analysis was done with Ingenuity Pathway Analysis (IPA). We found approximately 77% replacement of the endogenous intact cTnI with cTnI-ND in the transgenic mouse hearts with 1674 phospho-proteins and 2971 non-modified proteins. There were 73 significantly altered phospho-proteins; bioinformatic analysis identified the top canonical pathways as associated with integrin, protein kinase A, RhoA, and actin cytoskeleton signaling. Among the 73 phospho-proteins compared to controls cTnI-ND hearts demonstrated a significant decrease in paxillin and YAP1, which are known to play a role in cell mechano-sensing pathways. Our data indicate that cTnI-ND modifications in the sarcomere are sufficient to initiate changes in the phospho-signaling profile that may underly the chronic-adaptive response associated with cTnI cleavage in response to stressors by modifying mechano-sensitive signaling pathways.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Cytoskeleton; Heart; Integrin; Mouse; Paxillin; Sarcomeres

Mesh:

Substances:

Year:  2022        PMID: 35316461     DOI: 10.1007/s11010-022-04414-3

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  34 in total

1.  A proteolytic NH2-terminal truncation of cardiac troponin I that is up-regulated in simulated microgravity.

Authors:  Z B Yu; L F Zhang; J P Jin
Journal:  J Biol Chem       Date:  2001-02-08       Impact factor: 5.157

2.  Proteolytic N-terminal truncation of cardiac troponin I enhances ventricular diastolic function.

Authors:  John C Barbato; Qi-Quan Huang; M Moazzem Hossain; Meredith Bond; Jian-Ping Jin
Journal:  J Biol Chem       Date:  2004-12-20       Impact factor: 5.157

3.  Cardiac troponin I tyrosine 26 phosphorylation decreases myofilament Ca2+ sensitivity and accelerates deactivation.

Authors:  Hussam E Salhi; Shane D Walton; Nathan C Hassel; Elizabeth A Brundage; Pieter P de Tombe; Paul M L Janssen; Jonathan P Davis; Brandon J Biesiadecki
Journal:  J Mol Cell Cardiol       Date:  2014-09-22       Impact factor: 5.000

4.  Phosphorylation of Troponin I finely controls the positioning of Troponin for the optimal regulation of cardiac muscle contraction.

Authors:  Ehsan Kachooei; Nicole M Cordina; Phani R Potluri; Joanna A Guse; Dane McCamey; Louise J Brown
Journal:  J Mol Cell Cardiol       Date:  2020-10-18       Impact factor: 5.000

5.  Sphingosine-1-Phosphate Receptor Modulator, FTY720, Improves Diastolic Dysfunction and Partially Reverses Atrial Remodeling in a Tm-E180G Mouse Model Linked to Hypertrophic Cardiomyopathy.

Authors:  David M Ryba; Chad M Warren; Chehade N Karam; Robert T Davis; Shamim A K Chowdhury; Manuel G Alvarez; Maximilian McCann; Chong Wee Liew; David F Wieczorek; Peter Varga; R John Solaro; Beata M Wolska
Journal:  Circ Heart Fail       Date:  2019-11-05       Impact factor: 8.790

6.  Removal of the cardiac troponin I N-terminal extension improves cardiac function in aged mice.

Authors:  Brandon J Biesiadecki; Kittipong Tachampa; Chao Yuan; Jian-Ping Jin; Pieter P de Tombe; R John Solaro
Journal:  J Biol Chem       Date:  2010-04-21       Impact factor: 5.157

Review 7.  Integration of troponin I phosphorylation with cardiac regulatory networks.

Authors:  R John Solaro; Marcus Henze; Tomoyoshi Kobayashi
Journal:  Circ Res       Date:  2013-01-18       Impact factor: 17.367

8.  Removal of the N-terminal extension of cardiac troponin I as a functional compensation for impaired myocardial beta-adrenergic signaling.

Authors:  Han-Zhong Feng; Min Chen; Lee S Weinstein; Jian-Ping Jin
Journal:  J Biol Chem       Date:  2008-09-24       Impact factor: 5.157

9.  Causal analysis approaches in Ingenuity Pathway Analysis.

Authors:  Andreas Krämer; Jeff Green; Jack Pollard; Stuart Tugendreich
Journal:  Bioinformatics       Date:  2013-12-13       Impact factor: 6.937

10.  Evaluating multiplexed quantitative phosphopeptide analysis on a hybrid quadrupole mass filter/linear ion trap/orbitrap mass spectrometer.

Authors:  Brian K Erickson; Mark P Jedrychowski; Graeme C McAlister; Robert A Everley; Ryan Kunz; Steven P Gygi
Journal:  Anal Chem       Date:  2015-01-06       Impact factor: 6.986

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.